POST-ERCP PANCREATITIS
Clinical trials for POST-ERCP PANCREATITIS explained in plain language.
Never miss a new study
Get alerted when new POST-ERCP PANCREATITIS trials appear
Sign up with your email to follow new studies for POST-ERCP PANCREATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Finding the sweet spot: how long should a protective pancreatic stent stay in?
Disease control Not yet recruitingThis study aims to find the safest time to remove a small, temporary tube (stent) placed in the pancreas during a procedure called ERCP. Researchers will compare removing the stent within 10 days to leaving it in place for 4 weeks to 3 months. The goal is to see which timing caus…
Matched conditions: POST-ERCP PANCREATITIS
Phase: NA • Sponsor: Johann Wolfgang Goethe University Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Higher dose tested to stop painful complication after common procedure
Prevention Not yet recruitingThis study aims to prevent a painful pancreas inflammation that can happen after a common medical procedure called ERCP. It will test if a 200 mg dose of a standard anti-inflammatory drug (indomethacin) works better than the usual 100 mg dose for over 1,000 high-risk patients. Th…
Matched conditions: POST-ERCP PANCREATITIS
Phase: PHASE4 • Sponsor: The First Affiliated Hospital of Anhui Medical University • Aim: Prevention
Last updated Mar 27, 2026 12:40 UTC